The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peterson, M.
Right arrow Articles by Sant, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peterson, M.
Right arrow Articles by Sant, A. J.
The Journal of Immunology, 1998, 161: 2961-2967.
Copyright © 1998 by The American Association of Immunologists

The Inability of the Nonobese Diabetic Class II Molecule to Form Stable Peptide Complexes Does Not Reflect a Failure to Interact Productively with DM1

Mary Peterson and Andrea J. Sant2

Department of Pathology, Committees on Immunology and Cancer Biology, University of Chicago, Chicago, IL 60637

Sequence variability in MHC class II molecules plays a major role in genetically determined susceptibility to insulin-dependent diabetes mellitus (IDDM). It is not yet clear whether MHC class II polymorphism allows selective binding of diabetogenic peptides or regulates some key intracellular events associated with class II-restricted Ag presentation. In this study, we have employed gene transfer techniques to analyze the intracellular events that control peptide acquisition by the unique class II molecule expressed by nonobese diabetic mice (I-Ag7). This structurally unique class II molecule fails to demonstrate stable binding to antigenic peptides and fails to undergo the conformational change associated with stable peptide binding to class II molecules. The experiments reported here demonstrate that I-Ag7 can productively associate with two protein cofactors important in class II-restricted Ag presentation, invariant chain (Ii) and DM. DM participates in the removal of the Ii-derived class II-associated Ii chain peptide and the p12 degradation product from the I-Ag7 molecule. In addition, I-Ag7 undergoes a conformational change when DM is expressed within the APC. Finally, DM can mediate accumulation of peptide/class II complexes on the surface of APCs. Collectively, our experiments indicate that the failure of the I-Ag7 molecule to stably bind peptide cannot be attributed to a failure to interact with the DM or Ii glycoproteins.




This article has been cited by other articles:


Home page
 Int ImmunolHome page
A. Gardiner, K. A. Richards, A. J. Sant, and L. S. Arneson
Conformation of MHC class II I-Ag7 is sensitive to the P9 anchor amino acid in bound peptide
Int. Immunol., September 1, 2007; 19(9): 1103 - 1113.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. H. Koonce and E. K. Bikoff
Dissecting MHC Class II Export, B Cell Maturation, and DM Stability Defects in Invariant Chain Mutant Mice
J. Immunol., September 1, 2004; 173(5): 3271 - 3280.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
A. C. Anderson and V. K. Kuchroo
Expression of Self-antigen in the Thymus: A Little Goes a Long Way
J. Exp. Med., December 1, 2003; 198(11): 1627 - 1629.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
S. B. Lovitch, S. J. Petzold, and E. R. Unanue
Cutting Edge: H-2DM Is Responsible for the Large Differences in Presentation Among Peptides Selected by I-Ak During Antigen Processing
J. Immunol., September 1, 2003; 171(5): 2183 - 2186.
[Abstract] [Full Text] [PDF]

Home page
 Protein Eng Des SelHome page
S. E. Starwalt, E. L. Masteller, J. A. Bluestone, and D. M. Kranz
Directed evolution of a single-chain class II MHC product by yeast display
Protein Eng. Des. Sel., February 1, 2003; 16(2): 147 - 156.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Bhatnagar, P. J. Milburn, M. Lobigs, R. V. Blanden, and A. M. Gautam
Nonobese Diabetic Mice Display Elevated Levels of Class II-Associated Invariant Chain Peptide Associated with I-Ag7 on the Cell Surface
J. Immunol., April 1, 2001; 166(7): 4490 - 4497.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
N. K. Nanda and A. J. Sant
Dm Determines the Cryptic and Immunodominant Fate of T Cell Epitopes
J. Exp. Med., September 18, 2000; 192(6): 781 - 788.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Stratmann, V. Apostolopoulos, V. Mallet-Designe, A. L. Corper, C. A. Scott, I. A. Wilson, A. S. Kang, and L. Teyton
The I-Ag7 MHC Class II Molecule Linked to Murine Diabetes Is a Promiscuous Peptide Binder
J. Immunol., September 15, 2000; 165(6): 3214 - 3225.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. S. Arneson, M. Peterson, and A. J. Sant
The MHC Class II Molecule I-Ag7 Exists in Alternate Conformations That Are Peptide Dependent
J. Immunol., August 15, 2000; 165(4): 2059 - 2067.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
S. Gregori, E. Bono, F. Gallazzi, J. Hammer, L. C. Harrison, and L. Adorini
The motif for peptide binding to the insulin-dependent diabetes mellitus-associated class II MHC molecule I-Ag7 validated by phage display library
Int. Immunol., April 1, 2000; 12(4): 493 - 503.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
D. H.F. Hausmann, B. Yu, S. Hausmann, and K. W. Wucherpfennig
pH-dependent Peptide Binding Properties of the Type I Diabetes-associated I-Ag7 Molecule: Rapid Release of CLIP at an Endosomal pH
J. Exp. Med., June 7, 1999; 189(11): 1723 - 1734.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.